Showing results (901-910 of 2,400) with videos related to
Sort By:
Pageof 240
Future Medicinal Chemistry|February 6, 2018
Amyloid β-targeted metal complexes for potential applications in Alzheimer's diseaseHao Liu, Yunwei Qu, Xiaohui WangFuture Medicinal Chemistry|August 26, 2017
The potential role of in silico approaches to identify novel bioactive molecules from natural resourcesAbdurrahman Olğaç, Ilkay Erdogan Orhan, Erden BanogluFuture Medicinal Chemistry|January 31, 2018
Atropisomerism in medicinal chemistry: challenges and opportunitiesSean T Toenjes, Jeffrey L GustafsonFuture Medicinal Chemistry|January 20, 2018
Strategies to overcome resistance mutations of Bruton's tyrosine kinase inhibitor ibrutinibLinyi Liu, Bingyu Shi, Xiangqian Wang, et al.Future Medicinal Chemistry|January 23, 2018
Common structural and pharmacophoric features of mPGES-1 and LTC4SNisha S Devi, Padmapriya Paragi-Vedanthi, Andreas Bender, et al.Future Medicinal Chemistry|May 13, 2022
Synthesis and in vitro studies for structure-based design of novel chalcones as antitubercular agents targeting InhALoganathan S Dhivya, Balappaudayar R Pradeepa, Sabarathinam SarveshFuture Medicinal Chemistry|May 10, 2022
Factorial design in the optimization and study 'in combo' of derivatives of imidazo[1,2-a]azines in the COX´s isoforms inhibitionMiguel Guerrero-González, María-Elena Campos Aldrete, Marco Antonio Meraz-RiosFuture Medicinal Chemistry|May 31, 2022
9-Cyclopropylmethoxy-dihydrotetrabenazine and its stereoisomers as vesicular monoamine transporter-2 inhibitorsWenyan Wang, Shilan Lin, Guangying Du, et al.Future Medicinal Chemistry|July 7, 2021
Design and identification of two novel resveratrol derivatives as potential LSD1 inhibitorsYongtao Xu, Yunlong Gao, Min Yang, et al.Future Medicinal Chemistry|July 9, 2021
Structural characteristics of small-molecule inhibitors targeting FTO demethylaseShuting Gao, Xitong Li, Miao Zhang, et al.Pageof 240